Site Search

Share

X

Search Results

Victory for Public Health: ACS CAN Applauds Decision to Reject Flawed Biomarker Legislation

... CAN) in West Virginia: "The American Cancer Society Cancer Action Network (ACS CAN) applauds the Senate for not supporting House Bill 4753, the biomarker testing legislation, which was supposed to allow West Virginians to get the testing they need and not fall farther behind other states. West Virginia patients deserve access to proven and necessary biomarker tests that can allow them to benefit from the right treatments at the right time – often leading to improved health outcomes, better ...

Advocates Hold Cancer Action Day at State House, Urging Lawmakers to Expand Access to Biomarker Testing & Address Affordability Concerns

... voice with lawmakers by holding an annual Cancer Action Day.  Specifically, the advocates urged support of a proposal to improve access to biomarker testing (SB 120) and legislation relative to insurance cost sharing calculations (SB 17). They also asked lawmakers to protect level funding for ... Program, the Breast & Cervical Cancer Screening Program and the State Cancer Registry. Volunteers met with lawmakers to discuss the role of biomarker testing in connecting patients with the precision medicine treatments that have been proven to reduce risk of death and improve quality ...

Texas Becomes Latest State to Improve Access to Biomarker Testing, Beating New York in Push to Prioritize Precision Medicine

... TX – MAY 30, 2023 – Yesterday, Texas Governor Greg Abbott signed Senate Bill 989 into law, making Texas the 11 th state to expand access to biomarker testing. New York is considering comparable legislation through Assembly Bill 1673 / Senate Bill 1196. The American Cancer Society Cancer Action ... responded to the legislative victory in Texas with the following statement:   “Texas has joined a growing list of states expanding access to biomarker testing. The clock is ticking for New York to do the same. We cannot wait any longer to act on Assembly Bill 1673 / Senate Bill 1196. ...

New Survey: Top Barriers to Biomarker Use in Cancer Care Include Coverage and Cost Concerns

... Network (ACS CAN) released new survey data today examining some of the most common barriers providers face in performing recommended cancer biomarker testing. The survey of 315 oncology providers found lab turnaround time was the greatest challenge to biomarker testing (41%), followed by patient concerns about out-of-pocket costs (39%) and insurance coverage of biomarker tests (37%). The majority ...

Thank You to Our 2023 Lights of Hope Sponsors!

We could not accomplish the critical cancer advocacy work that we do without the generosity of our sponsors.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid.  ...

Cancer Advocates Commend Colorado Lawmakers for Positive First Step in Opening Door to Precision Medicine

... Cancer Society Cancer Action Network (ACS CAN) applauds the Colorado General Assembly for taking a great first step to increasing access to biomarker testing by passing SB24-124. The bill was met with strong bi-partisan support in both the House and Senate. With the legislative process now ... enacted, the policy would help connect more patients diagnosed with cancer or other diseases with the right treatment at the right time through biomarker testing .  The bill would ensure more patients with private insurance will have health insurance coverage for the biomarker testing they ...

The Right Treatment at the Right Time

... are often used to help determine the best treatment for a patient, but not all communities are benefitting from the latest advancements in biomarker testing and precision medicine. Video of overcoming_barriers_to_biomarker_testing_to_improve_outcomes_for_cancer_patients Progress in improving cancer outcomes increasingly involves the use of precision ...

Georgia General Assembly Passes Bill That Could Improve Cancer Survivorship by Expanding Access to Biomarker Testing, Necessary First Step in Personalizing Treatment

... 2023 – After a final vote by the Senate, the Georgia General Assembly today passed a bill (HB 85) that is expected to provide more access to biomarker testing, which is testing that can help physicians to identify the most effective treatment for a patient’s disease.   Revolutionizing cancer treatment over the last few decades, biomarker testing can provide access to targeted treatment; tailoring care to a person’s individual disease. Targeted therapies often result in ...

Legislation Aimed at Improving Health Outcomes for Pennsylvanians Heads to the Governor’s Desk

Earlier today, the Pennsylvania State Senate unanimously passed House Bill 1754, the bipartisan proposal to increase access to biomarker testing. The bill will now go to Governor Shapiro’s desk, providing him the opportunity to ensure coverage of this essential testing for more Pennsylvanians. The American Cancer Society Cancer Action Network (ACS CAN) and the PA Biomarker Testing Coalition are advocating for this significant policy change to ensure more cancer patients and people with other illnesses and ...

Lawmakers Should Take Critical Step for Cancer Treatment in Tennessee in 2025

... the American Cancer Society Cancer Action Network (ACS CAN) urges them to prioritize legislation which would allow more Tennesseans to access biomarker testing, an increasingly important part of cancer care. In the case of a cancer diagnosis, biomarker testing allows doctors to precisely target a specific cancer, saving some patients from more generalized treatments like chemo and ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy